Development of a novel radiopharmaceutical agent for non-invasive immunotherapy target detection and CAR T combination therapy in neuroblastoma
Development of a novel radiopharmaceutical agent for non-invasive immunotherapy target detection and CAR T combination therapy in neuroblastoma
Dr. Rosa Nguyen, M.D., Ph.D. – National Cancer Institute, NIH NCI Pediatric Oncology, Bethesda, MD
Targeting the HMGA1 Chromatin Regulator in MLL1-Rearranged Pediatric Leukemia
Targeting the HMGA1 Chromatin Regulator in MLL1-Rearranged Pediatric Leukemia
Dr. Linda Resar – Johns Hopkins University School of Medicine, Baltimore, MD
Deciphering the Immune Microenvironment in Alveolar Rhabdomyosarcoma
Deciphering the Immune Microenvironment in Alveolar Rhabdomyosarcoma
Dr. Brian Ladle - Johns Hopkins University School of Medicine, Baltimore, MD
Epigenetic targeting of radiation resistant medulloblastoma
Epigenetic targeting of radiation resistant medulloblastoma
Johns Hopkins University, Baltimore, MD
Activation of NF-kB in Neuroblastoma Myeloid Cells
Activation of NF-kB in Neuroblastoma Myeloid Cells
Johns Hopkins University School of Medicine, Baltimore, MD